WallStreetZenWallStreetZen

NASDAQ: CYCC
Cyclacel Pharmaceuticals Inc Stock Ownership - Who owns Cyclacel Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Cyclacel Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Paul McBarronE. VP Fin CFO COO and Secretary2023-12-211,886$3.32
$6.25kBuy
Spiro George RombotisPresident and CEO2023-12-216,070$3.32
$20.12kBuy

1 of 1

CYCC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYCC insiders and whales buy or sell their stock.

CYCC Shareholders

What type of owners hold Cyclacel Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe142.18%2,806,900$2.98MInsider
Stanley Morgan115.33%2,276,852$2.41MInsider
James E. Flynn70.16%1,385,091$1.47MInsider
Kevin C. Tang21.56%425,700$451.24kInsider
Armistice Capital LLC6.79%134,000$142.04kInstitution
Spiro George Rombotis3.48%68,658$72.78kInsider
Eastern Capital Ltd3.34%65,863$69.81kInsider
Judy Chiao2.94%58,008$61.49kInsider
Lloyd Sems2.61%51,529$54.62kInsider
Kenneth M. Ferguson2.28%44,952$47.65kInsider

1 of 3

CYCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYCC2.96%97.04%Net Buying
DRMA0.45%99.55%
SLRX0.22%99.78%
NBY0.02%99.98%
INM5.27%8.10%Net BuyingNet Selling
View Top Biotech Stocks

Cyclacel Pharmaceuticals Stock Ownership FAQ

Who owns Cyclacel Pharmaceuticals?

Cyclacel Pharmaceuticals (NASDAQ: CYCC) is owned by 11.62% institutional shareholders, 381.33% Cyclacel Pharmaceuticals insiders, and 0.00% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Cyclacel Pharmaceuticals shareholder, owning 2.81M shares representing 142.18% of the company. Austin W. Greenhouse David M. Marxe's Cyclacel Pharmaceuticals shares are currently valued at $2.98M.

If you're new to stock investing, here's how to buy Cyclacel Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.